Abstract
BackgroundMelanoma is categorized as an immunologically ‘cold’ tumor due to its unresponsiveness to immunotherapies. Efforts to enhance the immune response against tumor cells have focused on manipulating exhausted cytotoxic T...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
